Considerations for Practical Execution of a RBQM Strategy

Presented by

Crystal Stone, Director, Customer Engagement and Amanda Coogan, Product Specialist

About this talk

Today, risk-based quality management (RBQM) of your clinical trial can be simple thanks to both integrated and standalone technology solutions. Such technologies can provide seamless, in-depth, real-time insights into every aspect of your trial, simplifying overall trial management and informing decisions that both limit risks and save time and money. Yet, many people find the prospect of implementation daunting. Others plunge ahead without proper preparation, neglecting to establish internal processes or success metrics or to identify key stakeholders and decision-makers. As a result, they face huge roadblocks that may even derail the entire process. It doesn’t have to be that way. Join Remarque Systems specialists Crystal Stone and Amanda Coogan for a first-hand look at best practices in implementing RBQM technology and successfully utilizing the resultant output.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (45)
Subscribers (2054)
Premier Research is a clinical research company, dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.